Serum hepcidin concentrations decline during pregnancy and may identify iron deficiency: Analysis of a longitudinal pregnancy cohort in the Gambia

Journal of Nutrition

Volumn 147, Issue 6, 2017, Pages 1131-1137

  Bah, Amat ^a   Pasricha, Sant Rayn ^b   Jallow, Momodou W ^a   Sise, Ebrima A ^a   Wegmuller, Rita ^a   Armitage, Andrew E ^b   Drakesmith, Hal ^b   Moore, Sophie E ^c   Prentice, Andrew M ^d  

^a MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

Anemia; Diagnostic; Hepcidin; Iron deficiency; Pregnancy

Indexed keywords

C REACTIVE PROTEIN; FERRITIN; FOLIC ACID; HEMOGLOBIN; HEPCIDIN; IRON; TRANSFERRIN RECEPTOR;

ARTICLE; COHORT ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIET SUPPLEMENTATION; ERYTHROPOIESIS; FEMALE; GAMBIA; HUMAN; INFLAMMATION; IRON DEFICIENCY; IRON STORAGE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; PREGNANCY; RANDOMIZED CONTROLLED TRIAL; SECOND TRIMESTER PREGNANCY; SENSITIVITY AND SPECIFICITY; SERUM; ADULT; ANEMIA, IRON-DEFICIENCY; AREA UNDER THE CURVE; BLOOD; COMPLICATION; DEFICIENCY; GESTATIONAL AGE; METABOLISM; PREGNANCY COMPLICATIONS; PREVALENCE; RECEIVER OPERATING CHARACTERISTIC; YOUNG ADULT;

ADULT; ANEMIA, IRON-DEFICIENCY; AREA UNDER CURVE; C-REACTIVE PROTEIN; COHORT STUDIES; ERYTHROPOIESIS; FEMALE; FERRITINS; GAMBIA; GESTATIONAL AGE; HEMOGLOBINS; HEPCIDINS; HUMANS; INFLAMMATION; IRON; LONGITUDINAL STUDIES; PREGNANCY; PREGNANCY COMPLICATIONS; PREVALENCE; RECEPTORS, TRANSFERRIN; ROC CURVE; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 85021162908     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.116.245373     Document Type: Article

References (45)

1. WHO. The global prevalence of anaemia in 2011. Geneva (Switzerland): WHO Document Production Services; 2015
2. WHO. The World Health Report: reducing risks, promoting healthy life. Geneva (Switzerland): WHO; 2002
3. Haider BA, Olofin I, Wang M, Spiegelman D, Ezzati M, Fawzi WW; Nutrition Impact Model Study Group. Anaemia, prenatal iron use, and risk of adverse pregnancy outcomes: systematic review and meta-analysis. BMJ 2013;346:f3443
4. WHO. Daily iron and folic acid supplementation during pregnancy [Internet] [cited 2016 Oct 4]. Available from: http://www.who.int/elena/titles/daily_iron_pregnancy/en/
5. Drakesmith H, Prentice AM. Hepcidin and the iron-infection axis. Science 2012;338:768-72
6. Jones E, Pasricha SR, Allen A, Evans P, Fisher CA, Wray K, Premawardhena A, Bandara D, Perera A, Webster C, et al. Hepcidin is suppressed by erythropoiesis in hemoglobin E beta-thalassemia and beta-thalassemia trait. Blood 2015;125:873-80
7. WHO. Iron deficiency anaemia assessment, prevention, and control. Guide for programme managers. WHO/NHD/01.3. Geneva (Switzerland): WHO; 2001
8. WHO. Worldwide prevalence of anaemia 1993-2005. Geneva (Switzerland): WHO; 2008
9. Garcia-Casal MN, Peña-Rosas JP, Pasricha S-R. Rethinking ferritin cutoffs for iron deficiency and overload. Lancet Haematol 2014;1:e92-4
10. Cook JD, Flowers CH, Skikne BS. The quantitative assessment of body iron. Blood 2003;101:3359-64
11. Ganz T. Hepcidin and iron regulation, 10 years later. Blood 2011;117: 4425-33
12. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004;306:2090-3
13. Girelli D, Nemeth E, Swinkels DW. Hepcidin in the diagnosis of iron disorders. Blood 2016;127:2809-13
14. Pasricha SR, Atkinson SH, Armitage AE, Khandwala S, Veenemans J, Cox SE, Eddowes LA, Hayes T, Doherty CP, Demir AY, et al. Expression of the iron hormone hepcidin distinguishes different types of anemia in African children. Sci Transl Med 2014;6:235re3
15. Pasricha SR, McQuilten Z, Westerman M, Keller A, Nemeth E, Ganz T, Wood E. Serum hepcidin as a diagnostic test of iron deficiency in premenopausal female blood donors. Haematologica 2011;96:1099-105
16. Koenig MD, Tussing-Humphreys L, Day J, Cadwell B, Nemeth E. Hepcidin and iron homeostasis during pregnancy. Nutrients 2014;6:3062-83
17. Whittaker PG, Lind T, Williams JG. Iron absorption during normal human pregnancy: a study using stable isotopes. Br J Nutr 1991;65:457-63
18. Schulze KJ, Christian P, Ruczinski I, Ray AL, Nath A, Wu LS, Semba RD. Hepcidin and iron status among pregnant women in Bangladesh. Asia Pac J Clin Nutr 2008;17:451-6
19. Hou Y, Zhang S, Wang L, Li J, Qu G, He J, Rong H, Ji H, Liu S. Estrogen regulates iron homeostasis through governing hepatic hepcidin expression via an estrogen response element. Gene 2012;511:398-403
20. Li X, Rhee DK, Malhotra R, Mayeur C, Hurst LA, Ager E, Shelton G, Kramer Y, McCulloh D, Keefe D, et al. Progesterone receptor membrane component-1 regulates hepcidin biosynthesis. J Clin Invest 2016;126:389-401
21. Moore SE, Fulford AJ, Darboe MK, Jobarteh ML, Jarjou LM, Prentice AM. A randomized trial to investigate the effects of pre-natal and infant nutritional supplementation on infant immune development in rural Gambia: the ENID trial: Early Nutrition And Immune Development. BMC Pregnancy Childbirth 2012;12:107
22. The Gambia Bureau of Statistics; ICF International. The Gambia demographic and health survey 2013. Banjul (Gambia) and Rockville (MD): Gambia Bureau of Statistics and ICF International; 2014
23. Minchella PA, Armitage AE, Darboe B, Jallow MW, Drakesmith H, Jaye A, Prentice AM, McDermid JM. Elevated hepcidin is part of a complex relation that links mortality with iron homeostasis and anemia in men and women with HIV infection. J Nutr 2015;145:1194-201
24. WHO. Serum ferritin concentrations for the assessment of iron status and iron deficiency in populations. Geneva (Switzerland): WHO; 2011
25. Bothwell TH. Iron requirements in pregnancy and strategies to meet them. Am J Clin Nutr 2000;72(1 Suppl):257S-64S
26. Pasricha SR. Should we screen for iron deficiency anaemia? A review of the evidence and recent recommendations. Pathology 2012;44:139-47
27. Mei Z, Cogswell ME, Parvanta I, Lynch S, Beard JL, Stoltzfus RJ, Grummer-Strawn LM. Hemoglobin and ferritin are currently the most efficient indicators of population response to iron interventions: an analysis of nine randomized controlled trials. J Nutr 2005;135(8):1974-80
28. van Santen S, Kroot JJ, Zijderveld G, Wiegerinck ET, Spaanderman ME, Swinkels DW. The iron regulatory hormone hepcidin is decreased in pregnancy: a prospective longitudinal study. Clin Chem Lab Med 2013;51(7):1395-401
29. Hedengran KK, Nelson D, Andersen MR, Stender S, Szecsi PB. Hepcidin levels are low during pregnancy and increase around delivery in women without iron deficiency-a prospective cohort study. JMatern Fetal Neonatal Med 2016;29(9):1506-8
30. Simavli S, Derbent AU, Uysal S, Turhan NO. Hepcidin, iron status, and inflammation variables among healthy pregnant women in the Turkish population. J Matern Fetal Neonatal Med 2014;27(1):75-9
31. Simavli S, Derbent AU, Keskin EA, Gumus, II, Uysal S, Turhan N. Do the first, second and third trimester maternal serum hepcidin concentrations clarify obstetric complications? J Matern Fetal Neonatal Med 2015;28(7):854-7
32. YoungMF, Griffin I, Pressman E, McIntyre AW, Cooper E, McNanley T, Harris ZL, Westerman M, O'Brien KO. Maternal hepcidin is associated with placental transfer of iron derived from dietary heme and nonheme sources. J Nutr 2012;142:33-9
33. Kautz L, Jung G, Valore EV, Rivella S, Nemeth E, Ganz T. Identification of erythroferrone as an erythroid regulator of iron metabolism. Nat Genet 2014;46:678-84
34. Byg KE, Milman N, Hansen S, Agger AO. Serum ferritin is a reliable, non-invasive test for iron status in pregnancy: comparison of ferritin with other iron status markers in a longitudinal study on healthy pregnant women; erythropoiesis. Hematology 2000;5:319-25
35. Mwangi MN, Roth JM, Smit MR, Trijsburg L, Mwangi AM, Demir AY, Wielders JP, Mens PF, Verweij JJ, Cox SE, et al. Effect of daily antenatal iron supplementation on plasmodium infection in Kenyan women: a randomized clinical trial. JAMA 2015;314:1009-20
36. National Institute for Health and Care Excellence. Antenatal care for uncomplicated pregnancies [Internet] [cited 2017 Feb 17]. Available from: https://www.nice.org.uk/guidance/cg62/chapter/1-Guidance
37. WHO. Guideline: intermittent iron and folic acid supplementation in non-anaemic pregnant women. Geneva (Switzerland): WHO; 2012
38. Oduro AR, Bojang KA, Conway DJ, Corrah T, Greenwood BM, Schellenberg D. Health centre surveys as a potential tool for monitoring malaria epidemiology by area and over time. PLoS One 2011;6:e26305
39. Abbassi-Ghanavati M, Greer LG, Cunningham FG. Pregnancy and laboratory studies: a reference table for clinicians. Obstet Gynecol 2009;114:1326-31
40. van der Vorm LN, Hendriks JC, Laarakkers CM, Klaver S, Armitage AE, Bamberg A, Geurts-Moespot AJ, Girelli D, Herkert M, Itkonen O, et al. Toward worldwide hepcidin assay harmonization: identification of a commutable secondary reference material. Clin Chem 2016;62:993-1001
41. Prentice AM, Doherty CP, Abrams SA, Cox SE, Atkinson SH, Verhoef H, Armitage AE, Drakesmith H. Hepcidin is the major predictor of erythrocyte iron incorporation in anemic African children. Blood 2012;119:1922-8
42. Ganz T. Systemic iron homeostasis. Physiol Rev 2013;93:1721-41
43. Corradini E, Meynard D, Wu Q, Chen S, Ventura P, Pietrangelo A, Babitt JL. Serum and liver iron differently regulate the bone morphogenetic protein 6 (BMP6)-SMAD signaling pathway in mice. Hepatology 2011;54:273-84
44. Bah A, Wegmuller R, Cerami C, Kendall L, Pasricha SR, Moore SE, Prentice AM. A double blind randomised controlled trial comparing standard dose of iron supplementation for pregnant women with two screen-and-treat approaches using hepcidin as a biomarker for ready and safe to receive iron. BMC Pregnancy Childbirth 2016; 16:157
45. Wegmüller R, Bah A, Kendall L, Goheen MM, Mulwa S, Cerami C, Moretti D, Prentice AM. Efficacy and safety of hepcidin-based screenand-treat approaches using two different doses versus a standard universal approach of iron supplementation in young children in rural Gambia: a double-blind randomised controlled trial. BMC Pediatr 2016;16:149